Details of Drug

Drug General Information (ID: D0331)
Drug Name	Choline salicylate
Drug Type	Small molecule
Drug Synonymous	2016-36-6; Arthropan; Syrap; Mundisal; Satibon; Actasal; Salicol; Artrobione; Arret; Choline salicylate B; (2-Hydroxyethyl)trimethylammonium salicylate; UNII-KD510K1IQW; Choline salicylic acid salt; Salicylic acid choline salt; Cholini salicylas [INN-Latin]; Salicylic acid, ion(1-), choline; Salicylate de choline [INN-French]; Salicilato de colina [INN-Spanish]; EINECS 217-948-8; KD510K1IQW; Choline salicylate [USAN:INN:BAN:JAN]; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 2-hydroxybenzoic acid (1:1) Click to Show/Hide
Disease Class	1A00-CA43: Postoperative inflammation
Therapeutic Class	Salicylates
Structure
Structure	3D Structure		2D Structure
Formula	C12H19NO4
InChI	1S/C7H6O3.C5H14NO/c8-6-4-2-1-3-5(6)7(9)10;1-6(2,3)4-5-7/h1-4,8H,(H,9,10);7H,4-5H2,1-3H3/q;+1/p-1
InChIKey	UDKCHVLMFQVBAA-UHFFFAOYSA-M
Canonical SMILES	C[N+](C)(C)CCO.C1=CC=C(C(=C1)C(=O)O)[O-]
External Link
	Pubchem ID	54686350
	CAS Number	2016-36-6
	CHEBI ID	3668
	TTD ID	D05QPW
	INTEDE ID	DR0316

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM004 Adsorption BM005 Altered gastric pH BM013 Competitive binding of plasma proteins BM027 Decreased renal excretion due to nephrotoxicity BM028 Competitive inhibition of renal tubular secretion BM029 Altered urine pH BM032 Decreased renal excretion (Unspecific) BM038 Additive CNS depression effects BM039 Additive CNS stimulant effects BM050 Increased risk of bleeding BM054 Increased risk of GI mucosal injury/bleeding risk BM055 Increased risk of hepatotoxicity BM058 Increased risk of hyperkalemia BM064 Increased risk of hypoglycemia BM070 Increased risk of metabolic acidosis BM072 Increased risk of nephrotoxicity BM089 Antagonize the effect of antihypertensive agents BM099 Antagonize the effect of uricosuric agents BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Choline salicylate
Affected gastrointestinal absorption
	Adsorption					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0021		Activated charcoal	C	5462310	Moderate		Inter Info	[31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55]
	Altered gastric pH					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0458		Dexlansoprazole	C16H14F3N3O2S	9578005	Minor		Inter Info	[321], [322], [323]
D0603		Esomeprazole	C17H19N3O3S	9568614	Minor		Inter Info	[321], [322], [323]
D0892		Lansoprazole	C16H14F3N3O2S	3883	Minor		Inter Info	[321], [322], [323]
D1179		Omeprazole	C17H19N3O3S	4594	Minor		Inter Info	[321], [322], [323]
D1222		Pantoprazole	C16H15F2N3O4S	4679	Minor		Inter Info	[321], [322], [323]
D1373		Rabeprazole	C18H21N3O3S	5029	Minor		Inter Info	[321], [322], [323]
Affected organization distribution
	Competitive binding of plasma proteins					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0012		Acetazolamide	C4H6N4O3S2	1986	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0207		Brinzolamide (ophthalmic)	C12H21N3O5S3	68844	Major		Inter Info	[5], [12], [13]
D0479		Diclofenamide	C6H6Cl2N2O4S2	3038	Major		Inter Info	[5], [12], [13]
D0521		Dorzolamide (ophthalmic)	C10H16N2O4S3	5284549	Major		Inter Info	[5], [12], [13]
D1018		Methazolamide	C5H8N4O3S2	4100	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[277]
D1677		Valproic acid	C8H16O2	3121	Moderate		Inter Info	[304], [305], [306], [307]
D1283		Phenytoin	C15H12N2O2	1775	Minor		Inter Info	[325], [326], [327], [328], [329]
Affected excretion pathways
	Decreased renal excretion due to nephrotoxicity					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[290], [291], [292]
	Competitive inhibition of renal tubular secretion					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1025		Methotrexate	C20H22N8O5	126941	Major		Inter Info	[20], [21], [22]
	Altered urine pH					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0049		Aluminum hydroxide	AlH3O3	10176082	Moderate		Inter Info	[68], [69], [70]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[68], [69], [70]
D0886		Lactic acid	C3H6O3	612	Moderate		Inter Info	[288], [152], [289]
D0967		Magaldrate	AlHMgO5S+2	3086011	Moderate		Inter Info	[68], [69], [70]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[68], [69], [70]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[68], [69], [70]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[68], [69], [70]
D1319		Potassium citrate	C6H5K3O7	13344	Moderate		Inter Info	[296], [297], [288], [152], [289]
D1478		Sodium acetate	C2H3NaO2	517045	Moderate		Inter Info	[296], [297], [288], [152], [289]
D1480		Sodium bicarbonate	CHNaO3	516892	Moderate		Inter Info	[296], [297], [288], [152], [289]
D1483		Sodium citrate	C6H5Na3O7	6224	Moderate		Inter Info	[296], [297], [288], [152], [289]
D1654		Tromethamine	C4H11NO3	6503	Moderate		Inter Info	[288], [152], [289]
	Decreased renal excretion (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[156], [157], [158]
D1323		Pralatrexate	C23H23N7O5	148121	Moderate		Inter Info	[298]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[99], [101], [102], [98], [103], [104], [100], [105], [106], [107], [108], [109], [110], [111]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[99], [101], [102], [98], [103], [104], [100], [105], [106], [107], [108], [109], [110], [111]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[99], [101], [102], [98], [103], [104], [100], [105], [106], [107], [108], [109], [110], [111]
	Additive CNS stimulant effects					Drug Num: 12
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0340		Cinoxacin	C12H10N2O5	2762	Moderate		Inter Info	[98], [99], [100]
D0573		Enoxacin	C15H17FN4O3	3229	Moderate		Inter Info	[100], [98], [99]
D0712		Gatifloxacin	C19H22FN3O4	5379	Moderate		Inter Info	[100], [98], [99]
D0740		Grepafloxacin	C19H22FN3O3	72474	Moderate		Inter Info	[100], [98], [99]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[99], [101], [102], [98], [103], [104], [100], [105], [106], [107], [108], [109], [110], [111]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[100], [98], [99]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[99], [101], [102], [98], [103], [104], [100], [105], [106], [107], [108], [109], [110], [111]
D1102		Nalidixic acid	C12H12N2O3	4421	Moderate		Inter Info	[100], [98], [99]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[100], [98], [99]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[99], [101], [102], [98], [103], [104], [100], [105], [106], [107], [108], [109], [110], [111]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Moderate		Inter Info	[100], [98], [99]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Moderate		Inter Info	[100], [98], [99]
	Increased risk of bleeding					Drug Num: 53
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1380		Ramucirumab	NA	NA	Major		Inter Info	[23]
D0005		Abciximab	NA	NA	Moderate		Inter Info	[24], [25], [26], [27]
D0047		Alteplase	NA	NA	Moderate		Inter Info	[61], [24], [62], [63], [64], [65], [66], [67]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[80], [81], [82]
D0088		Anistreplase	NA	NA	Moderate		Inter Info	[61], [62], [67]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0102		Ardeparin	C26H42N2O37S5	772	Moderate		Inter Info	[80], [81], [82]
D0104		Argatroban	C23H36N6O5S	92722	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0176		Betrixaban	C23H22ClN5O3	10275777	Moderate		Inter Info	[80], [81], [82]
D0189		Bivalirudin	C98H138N24O33	16129704	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0345		Citalopram	C20H21FN2O	2771	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0364		Clopidogrel	C16H16ClNO2S	60606	Moderate		Inter Info	[25], [150]
D0414		Dalteparin	C26H42N2O37S5	772	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0415		Danaparoid	NA	NA	Moderate		Inter Info	[80], [81], [82]
D0447		Desirudin	C287H440N80O110S6	16129703	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0451		Desvenlafaxine	C16H25NO2	125017	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0457		Dexfenfluramine	C12H16F3N	66265	Moderate		Inter Info	[115], [144], [145]
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[80], [81], [82]
D0537		Drotrecogin alfa	NA	NA	Moderate		Inter Info	[80], [81], [82]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0574		Enoxaparin	C26H42N2O37S5	772	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0586		Epoprostenol	C20H32O5	5282411	Moderate		Inter Info	[168], [169], [170]
D0588		Eptifibatide	C35H49N11O9S2	448812	Moderate		Inter Info	[24], [25], [26], [27]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D0690		Fondaparinux	C31H53N3O49S8	5282448	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0753		Heparin	C26H42N2O37S5	772	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0792		Iloprost	C22H32O4	5311181	Moderate		Inter Info	[168], [169], [170]
D0904		Lepirudin	C287H440N80O111S6	118856773	Moderate		Inter Info	[80], [81], [82]
D0920		Levomilnacipran	C15H22N2O	6917779	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1066		Milnacipran	C15H22N2O	65833	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1328		Prasugrel	C20H20FNO3S	6918456	Moderate		Inter Info	[299]
D1395		Reteplase	NA	NA	Moderate		Inter Info	[61], [24], [62], [63], [64], [65], [66], [67]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1464		Sibutramine	C17H26ClN	5210	Moderate		Inter Info	[115], [144], [145]
D1506		Streptokinase	C11H19NO2	9815560	Moderate		Inter Info	[61], [62], [67]
D1550		Tenecteplase	NA	NA	Moderate		Inter Info	[61], [24], [62], [63], [64], [65], [66], [67]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[4], [303]
D1588		Tinzaparin	C26H42N2O37S5	772	Moderate		Inter Info	[80], [81], [82]
D1593		Tirofiban	C22H36N2O5S	60947	Moderate		Inter Info	[24], [25], [26], [27]
D1625		Treprostinil	C23H34O5	6918140	Moderate		Inter Info	[168], [169], [170]
D1669		Urokinase	NA	NA	Moderate		Inter Info	[61], [24], [62], [63], [64], [65], [66], [67]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[112], [113], [114], [115], [3], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[83], [84], [80], [81], [85], [86], [87], [82]
D0368		Clove	NA	NA	Minor		Inter Info	[317], [318], [319], [320]
	Increased risk of GI mucosal injury/bleeding risk					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0882		Ketorolac	C15H13NO3	3826	Major		Inter Info	[16]
D0034		Alendronic acid	C4H13NO7P2	2088	Moderate		Inter Info	[56], [57], [58]
D0172		Betamethasone	C22H29FO5	9782	Moderate		Inter Info	[93], [94], [95], [96], [97]
D0215		Budesonide	C25H34O6	5281004	Moderate		Inter Info	[93], [94], [95], [96], [97]
D0436		Deflazacort	C25H31NO6	189821	Moderate		Inter Info	[93], [94], [95], [96], [97]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[93], [94], [95], [96], [97]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[56], [57], [58]
D0671		Fludrocortisone	C21H29FO5	31378	Moderate		Inter Info	[93], [94], [95], [96], [97]
D0773		Hydrocortisone	C21H30O5	5754	Moderate		Inter Info	[93], [94], [95], [96], [97]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[4], [270], [271], [56], [272], [57], [273], [58], [274], [275], [276]
D1041		Methylprednisolone	C22H30O5	6741	Moderate		Inter Info	[93], [94], [95], [96], [97]
D1217		Pamidronic acid	C3H11NO7P2	4674	Moderate		Inter Info	[56], [57], [58]
D1332		Prednisolone	C21H28O5	5755	Moderate		Inter Info	[93], [94], [95], [96], [97]
D1334		Prednisone	C21H26O5	5865	Moderate		Inter Info	[93], [94], [95], [96], [97]
D1412		Risedronic acid	C7H11NO7P2	5245	Moderate		Inter Info	[56], [57], [58]
D1584		Tiludronic acid	C7H9ClO6P2S	60937	Moderate		Inter Info	[56], [57], [58]
D1628		Triamcinolone	C21H27FO6	31307	Moderate		Inter Info	[93], [94], [95], [96], [97]
D1630		Triamcinolone (ophthalmic)	C21H27FO6	31307	Moderate		Inter Info	[95], [96], [97]
D1727		Zoledronic acid	C5H10N2O7P2	68740	Moderate		Inter Info	[4], [270], [271], [56], [272], [57], [273], [58], [274], [275], [276]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[324]
	Increased risk of hepatotoxicity					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[17], [18], [19]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[17], [18], [19]
	Increased risk of hyperkalemia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0536		Drospirenone	C24H30O3	68873	Moderate		Inter Info	[159], [160]
D0585		Eplerenone	C24H30O6	443872	Moderate		Inter Info	[161], [89], [90], [91], [162], [163], [164], [92], [165], [166], [167]
	Increased risk of hypoglycemia					Drug Num: 22
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0013		Acetohexamide	C15H20N2O4S	1989	Moderate		Inter Info	[28], [29], [30]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[28], [29], [30]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [28], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [29], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [30], [261], [262], [263], [264], [265], [266], [267], [268]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [28], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [29], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [30], [261], [262], [263], [264], [265], [266], [267], [268]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [28], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [29], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [30], [261], [262], [263], [264], [265], [266], [267], [268]
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Moderate		Inter Info	[178], [233], [250]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[178], [233], [250]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [278], [182], [183], [28], [184], [185], [186], [187], [188], [190], [191], [192], [194], [195], [196], [197], [198], [199], [200], [202], [204], [205], [206], [207], [208], [209], [210], [211], [212], [214], [217], [219], [220], [221], [224], [225], [227], [228], [229], [231], [279], [233], [280], [281], [238], [282], [283], [244], [246], [247], [248], [250], [252], [254], [256], [257], [30], [261], [262], [263], [284], [264], [265], [267], [268]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [278], [182], [183], [28], [184], [185], [186], [187], [188], [190], [191], [192], [194], [195], [196], [197], [198], [199], [200], [202], [204], [205], [206], [207], [208], [209], [210], [211], [212], [214], [217], [219], [220], [221], [224], [225], [227], [228], [229], [231], [279], [233], [280], [281], [238], [282], [283], [244], [246], [247], [248], [250], [252], [254], [256], [257], [30], [261], [262], [263], [284], [264], [265], [267], [268]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [278], [182], [183], [28], [184], [185], [186], [187], [188], [190], [191], [192], [194], [195], [196], [197], [198], [199], [200], [202], [204], [205], [206], [207], [208], [209], [210], [211], [212], [214], [217], [219], [220], [221], [224], [225], [227], [228], [229], [231], [279], [233], [280], [281], [238], [282], [283], [244], [246], [247], [248], [250], [252], [254], [256], [257], [30], [261], [262], [263], [284], [264], [265], [267], [268]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [278], [182], [183], [28], [184], [185], [186], [187], [188], [190], [191], [192], [194], [195], [196], [197], [198], [199], [200], [202], [204], [205], [206], [207], [208], [209], [210], [211], [212], [214], [217], [219], [220], [221], [224], [225], [227], [228], [229], [231], [279], [233], [280], [281], [238], [282], [283], [244], [246], [247], [248], [250], [252], [254], [256], [257], [30], [261], [262], [263], [284], [264], [265], [267], [268]
D0813		Insulin human	C257H383N65O77S6	118984375	Moderate		Inter Info	[178], [233], [250]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[178], [233], [250]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[178], [233], [250]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[178], [233], [250]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[178], [233], [250]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[178], [233], [250]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [278], [182], [183], [28], [184], [185], [186], [187], [188], [190], [191], [192], [194], [195], [196], [197], [198], [199], [200], [202], [204], [205], [206], [207], [208], [209], [210], [211], [212], [214], [217], [219], [220], [221], [224], [225], [227], [228], [229], [231], [279], [233], [280], [281], [238], [282], [283], [244], [246], [247], [248], [250], [252], [254], [256], [257], [30], [261], [262], [263], [284], [264], [265], [267], [268]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Moderate		Inter Info	[178], [233], [250]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [28], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [29], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [30], [261], [262], [263], [264], [265], [266], [267], [268]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[28], [29], [30]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[28], [29], [30]
	Increased risk of nephrotoxicity					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[14], [15]
D0056		Amikacin	C22H43N5O13	37768	Moderate		Inter Info	[71], [72], [73], [74], [75], [76]
D0057		Amikacin (liposome)	C22H43N5O13	37768	Moderate		Inter Info	[72], [73], [75]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[151], [152], [153], [154], [78], [155]
D0718		Gentamicin	C21H43N5O7	3467	Moderate		Inter Info	[71], [72], [73], [74], [75], [76]
D0876		Kanamycin	C18H36N4O11	6032	Moderate		Inter Info	[71], [72], [73], [74], [75], [76]
D1126		Netilmicin	C21H41N5O7	441306	Moderate		Inter Info	[72], [73], [75]
D1304		Plazomicin	C25H48N6O10	42613186	Moderate		Inter Info	[72], [73], [75]
D1507		Streptomycin	C21H39N7O12	19649	Moderate		Inter Info	[71], [72], [73], [74], [75], [76]
D1597		Tobramycin	C18H37N5O9	36294	Moderate		Inter Info	[71], [72], [73], [74], [75], [76]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[293], [294], [295]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[293], [294], [295]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antihypertensive agents					Drug Num: 44
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[4], [59], [60]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[77], [78], [79]
D0138		Azilsartan medoxomil	C30H24N4O8	135409642	Moderate		Inter Info	[88], [16], [89]
D0156		Benazepril	C24H28N2O5	5362124	Moderate		Inter Info	[90], [91], [92]
D0170		Bepridil	C24H34N2O	2351	Moderate		Inter Info	[77], [78], [79]
D0254		Captopril	C9H15NO3S	44093	Moderate		Inter Info	[90], [91], [92]
D0567		Enalapril	C20H28N2O5	5388962	Moderate		Inter Info	[90], [91], [92]
D0587		Eprosartan	C23H24N2O4S	5281037	Moderate		Inter Info	[88], [16], [89]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[77], [78], [79]
D0695		Fosinopril	C30H46NO7P	55891	Moderate		Inter Info	[90], [91], [92]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[269]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[77], [78], [79]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[77], [78], [79]
D0938		Lisinopril	C21H31N3O5	5362119	Moderate		Inter Info	[90], [91], [92]
D0954		Losartan	C22H23ClN6O	3961	Moderate		Inter Info	[88], [16], [89]
D1082		Moexipril	C27H34N2O7	91270	Moderate		Inter Info	[90], [91], [92]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[77], [78], [79]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[77], [78], [79]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[77], [78], [79]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[77], [78], [79]
D1170		Olmesartan	C24H26N6O3	158781	Moderate		Inter Info	[88], [16], [89]
D1256		Perindopril	C19H32N2O5	107807	Moderate		Inter Info	[90], [91], [92]
D1369		Quinapril	C25H30N2O5	54892	Moderate		Inter Info	[90], [91], [92]
D1379		Ramipril	C23H32N2O5	5362129	Moderate		Inter Info	[90], [91], [92]
D1545		Telmisartan	C33H30N4O2	65999	Moderate		Inter Info	[88], [16], [89]
D1618		Trandolapril	C24H34N2O5	5484727	Moderate		Inter Info	[90], [91], [92]
D1679		Valsartan	C24H29N5O3	60846	Moderate		Inter Info	[88], [16], [89]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[77], [78], [79]
D0010		Acebutolol	C18H28N2O4	1978	Minor		Inter Info	[308], [309], [310]
D0117		Atenolol	C14H22N2O3	2249	Minor		Inter Info	[308], [309], [310]
D0173		Betaxolol	C18H29NO3	2369	Minor		Inter Info	[308], [309], [310]
D0188		Bisoprolol	C18H31NO4	2405	Minor		Inter Info	[308], [309], [310]
D0265		Carteolol	C16H24N2O3	2583	Minor		Inter Info	[308], [309], [310]
D0267		Carvedilol	C24H26N2O4	2585	Minor		Inter Info	[308], [309], [310]
D0602		Esmolol	C16H25NO4	59768	Minor		Inter Info	[308], [309], [310]
D0884		Labetalol	C19H24N2O3	3869	Minor		Inter Info	[308], [309], [310]
D1049		Metoprolol	C15H25NO3	4171	Minor		Inter Info	[308], [309], [310]
D1098		Nadolol	C17H27NO4	39147	Minor		Inter Info	[308], [309], [310]
D1114		Nebivolol	C22H25F2NO4	71301	Minor		Inter Info	[308], [309], [310]
D1244		Penbutolol	C18H29NO2	37464	Minor		Inter Info	[308], [309], [310]
D1293		Pindolol	C14H20N2O2	4828	Minor		Inter Info	[308], [309], [310]
D1357		Propranolol	C16H21NO2	4946	Minor		Inter Info	[308], [309], [310]
D1498		Sotalol	C12H20N2O3S	5253	Minor		Inter Info	[308], [309], [310]
D1585		Timolol	C13H24N4O3S	33624	Minor		Inter Info	[308], [309], [310]
	Antagonize the effect of uricosuric agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1341		Probenecid	C13H19NO4S	4911	Moderate		Inter Info	[4], [300], [301], [302]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1822		Iodide I-123	I-	135300	Moderate		Inter Info	[285], [286], [287]
D0217		Bumetanide	C17H20N2O5S	2471	Minor		Inter Info	[311], [312], [313]
D1812		Hyaluronidase	C17H24BrNO2	91820602	Minor		Inter Info	[314], [315], [316]
D0613		Etacrynic acid	C13H12Cl2O4	3278	Minor		Inter Info	[311], [312], [313]
D0704		Furosemide	C12H11ClN2O5S	3440	Minor		Inter Info	[311], [312], [313]
D1611		Torasemide	C16H20N4O3S	41781	Minor		Inter Info	[311], [312], [313]

References
1	Anderson CJ, Kaufman PL, Sturm RJ "Toxicity of combined therapy with carbonic anhydrase inhibitors and aspirin." Am J Ophthalmol 86 (1978): 516-9. [PMID: 707596]
2	Canadian Pharmacists Association.
3	Cerner Multum, Inc. "Australian Product Information.".
4	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
5	Cowan RA, Hartnell GG, Lowdell CP, Baird IM, Leak AM "Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function." Br Med J (Clin Res Ed) 289 (1984): 347-8. [PMID: 6432091]
6	Favre L, Vallotton MB "Relationship of renal prostaglandins to three diuretics." Prostaglandins Leukot Med 14 (1984): 313-9. [PMID: 6589647]
7	Product Information. Azopt (brinzolamide ophthalmic). Alcon Laboratories Inc, Fort Worth, TX.
8	Product Information. Diamox (acetazolamide). Lederle Laboratories, Wayne, NJ.
9	Product Information. Trusopt (dorzolamide ophthalmic). Merck & Co, Inc, West Point, PA.
10	Rousseau P, Fuentevilla-Clifton A "Acetazolamide and salicylate interaction in the elderly: a case report." J Am Geriatr Soc 41 (1993): 868-9. [PMID: 8340566]
11	Sweeney KR, Chapron DJ, Antal EJ, Kramer PA "Differential effects of flurbiprofen and aspirin on acetazolamide disposition in humans." Br J Clin Pharmacol 27 (1989): 866-9. [PMID: 2757898]
12	Sweeney KR, Chapron DJ, Brandt JL, Gomolin IH, Feig PU, Kramer PA "Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation." Clin Pharmacol Ther 40 (1986): 518-24. [PMID: 3769383]
13	Sweeney KR, Chapron DJ, Kramer PA "Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro." J Pharm Sci 77 (1988): 751-6. [PMID: 3225768]
14	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
15	Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M "Fanconi Syndrome Due to Deferasirox." Am J Kidney Dis (2009):. [PMID: 19493602]
16	Product Information. Toradol (ketorolac). Roche Laboratories, Nutley, NJ.
17	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
18	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
19	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
20	Kraus A, Alarcon-Segovia D "Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia." J Rheumatol 18 (1991): 1274. [PMID: 1796967]
21	Steele WH, Lawrence JR, Stuart JF, McNeill CA. "The protein binding of methotrexate in the serum of patients with neoplastic disease."?Cancer Chemother Pharmacol. 1981;7(1):61-64.[PMID: 7340989]
22	Taylor JR, Halprin KM "Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding." Arch Dermatol 113 (1977): 588-91.[PMID: 856048]
23	Product Information. Cyramza (ramucirumab). Eli Lilly and Company, Indianapolis, IN.
24	Hirsch J, Dalen J, Guyatt G, American College of Chest Physicians "The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Physicians." Chest 119(1 Suppl) (2001): 1S-2S. [PMID: 11157638]
25	Klinkhardt U, Kirchmaier CM, Westrup D, Graff J, Mahnel R, Breddin HK, Harder S "Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A." Clin Pharmacol Ther 67 (2000): 305-13. [PMID: 10741635]
26	Product Information. Integrilin (eptifibatide). Schering Laboratories, Kenilworth, NJ.
27	Product Information. ReoPro (abciximab). Lilly, Eli and Company, Indianapolis, IN.
28	Christensen LK, Hansen JM, Kristensen M "Sulphaphenazole-induced hypoglycemic attacks in tolbutamide-treated diabetics." Lancet 2 (1963): 1298-301. [PMID: 14071924]
29	Field JB, Ohta M, Boyle C, Remer A "Potentiation of acetohexamide hypoglycemia by phenylbutazone." N Engl J Med 277 (1967): 889-94. [PMID: 6061822]
30	Turtle JR, Burgess JA "Hypoglycemic action of fenfluramine in diabetes mellitus." Diabetes 22 (1973): 858-67. [PMID: 4749404]
31	Bonuccelli U, Piccini P, Del Dotto P, Pavese N, D'Antonio P, Muratorio A "Apomorphine test in de novo Parkinson's disease." Funct Neurol 7 (1992): 295-8. [PMID: 1427361]
32	Chernish SM, Wolen RL, Rodda BE "Adsorption of propoxyphene hydrochloride by activated charcoal." Clin Toxicol 5 (1972): 317-29. [PMID: 5073815]
33	Decker WJ, Shpall RA, Corby DG "Inhibition of aspirin absorption by activated charcoal and apomorphine." Clin Pharmacol Ther 10 (1969): 710-3. [PMID: 5808464]
34	Dolgin JG, Nix DE, Sanchez J, Watson WA "Pharmacokinetic simulation of the effect of multiple-dose activated charcoal in phenytoin poisoning: report of two pediatric cases." DICP 25 (1991): 646-9. [PMID: 1877275]
35	Farrar HC, Herold DA, Reed MD "Acute valproic acid intoxication: enhanced drug clearance with oral-activated charcoal." Crit Care Med 21 (1993): 299-301. [PMID: 8428486]
36	Gadgil SD, Damle SR, Advani SH, Vaidya AB "Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate." Cancer Treat Rep 66 (1982): 1169-71. [PMID: 7083219]
37	Glab WN, Corby DG, Decker WJ, Coldiron VR "Decreased absorption of propoxyphene by activated charcoal." J Toxicol Clin Toxicol 19 (1982): 129-38. [PMID: 6125599]
38	Herrington AM, Clifton GD "Toxicology and management of acute drug ingestions in adults." Pharmacotherapy 15 (1995): 182-200. [PMID: 7624266]
39	Howard CE, Roberts RS, Ely DS, Moye RA "Use of multiple-dose activated charcoal in phenytoin toxicity." Ann Pharmacother 28 (1994): 201-3. [PMID: 8173135]
40	Ilkhanipour K, Yealy DM, Krenzelok EP "Activated charcoal surface area and its role in multiple-dose charcoal therapy." Am J Emerg Med 11 (1993): 583-5. [PMID: 8240556]
41	Karkkainen S, Neuvonen PJ "Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics." Int J Clin Pharmacol Ther Toxicol 23 (1985): 219-25. [PMID: 2987139]
42	Kivisto KT, Neuvonen PJ "The effect of cholestyramine and activated charcoal on glipizide absorption." Br J Clin Pharmacol 30 (1990): 733-6. [PMID: 2271372]
43	Knadler MP, Bergstrom RF, Callaghan JT, Obermeyer BD, Rubin A "Absorption studies of the H2-blocker nizatidine." Clin Pharmacol Ther 42 (1987): 514-20. [PMID: 2890459]
44	Naveau S, Bonhomme L, Preaux N, Chaput JC "A pure charcoal suspension for colonoscopic tattoo." Gastrointest Endosc 37 (1991): 624-5. [PMID: 1756921]
45	Neuvonen PJ "Clinical pharmacokinetics of oral activated charcoal in acute intoxications." Clin Pharmacokinet 7 (1982): 465-89. [PMID: 6761032]
46	Orisakwe OE "Activated charcoal: is failure to use it negligence or ignorance?" South Med J 87 (1994): 165-8. [PMID: 8115876]
47	Park GD, Spector R, Goldberg MJ, Johnson GF "Expanded role of charcoal therapy in the poisoned and overdosed patient." Arch Intern Med 146 (1986): 969-73. [PMID: 3516107]
48	Product Information. Trileptal (oxcarbazepine) Novartis Pharmaceuticals, East Hanover, NJ.
49	Reed MD "Oral activated charcoal therapy." Am J Emerg Med 6 (1988): 318. [PMID: 3370115]
50	Rowden AM, Spoor JE, Bertino JS, Jr "The effect of activated charcoal on phenytoin pharmacokinetics." Ann Emerg Med 19 (1990): 1144-7. [PMID: 2221521]
51	Saetta JP "Gastric decontaminating procedures: is it time to call a stop?" J R Soc Med 86 (1993): 396-9. [PMID: 8371247]
52	Scheufler E, Bos I "Influence of peroral charcoal on pharmacokinetics and intestinal toxicity of intravenously given methotrexate." Arch Int Pharmacodyn Ther 261 (1983): 180-5. [PMID: 6838279]
53	Wakabayashi Y, Maruyama S, Hachimura K, Ohwada T "Activated charcoal interrupts enteroenteric circulation of phenobarbital." J Toxicol Clin Toxicol 32 (1994): 419-24. [PMID: 8057401]
54	Watson WA "Factors influencing the clinical efficacy of activated charcoal." Drug Intell Clin Pharm 21 (1987): 160-6. [PMID: 3549212]
55	Wing LM, Miners JO, Birkett DJ, et al "Lidocaine disposition: sex differences and effects of cimetidine." Clin Pharmacol Ther 35 (1984): 695-701. [PMID: 6713782]
56	Product Information. Actonel (risedronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
57	Product Information. Bonefos (clodronate). Rhone-Poulenc Rorer Canada Inc, Laval, QC.
58	Product Information. Didronel I.V. Infusion (etidronate). MGI Pharma Inc, Minnetonka, MN.
59	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
60	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA."
61	Harder S, Klinkhardt U "Thrombolytics: drug interactions of clinical significance." Drug Saf 23 (2000): 391-9. [PMID: 11085346]
62	Product Information. Abbokinase (urokinase). Abbott Pharmaceutical, Abbott Park, IL.
63	Product Information. Activase (alteplase). Genentech, South San Francisco, CA.
64	Product Information. Retavase (reteplase). Boehringer Mannheim, Gaithersburg, MD.
65	Product Information. Streptase (streptokinase). Astra USA, Westborough, MA.
66	Product Information. Ticlid (ticlopidine). Syntex Laboratories Inc, Palo Alto, CA.
67	Product Information. TNKase (tenecteplase) Genentech, South San Francisco, CA.
68	Covington TR, Lawson LC, Young LL, eds. "Handbook of Nonprescription Drugs. 10th ed." Washington, DC: American Pharmaceutical Association (1993):.
69	Gaspari F, Vigano G, Locatelli M, Remuzzi G "Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis." Am J Kidney Dis 11 (1988): 338-42
70	Levy G, Lampman T, Kamath BL, Garrettson LK "Decreased serum salicylate concentrations in children with rheumatic fever treated with antacid." N Engl J Med 293 (1975): 323-5
71	Assael BM, Chiabrando C, Gagliardi L, Noseda A, Bamonte F, Salmona M "Prostaglandins and aminoglycoside nephrotoxicity." Toxicol Appl Pharmacol 78 (1985): 386-94. [PMID: 4049389]
72	Farag MM, Mikhail MR, Abdel-Meguid E, Abdel-Tawab S "Assessment of gentamicin-induced nephrotoxicity in rats treated with low doses of ibuprofen and diclofenac sodium." Clin Sci 91 (1996): 187-91. [PMID: 8795442]
73	Gagliardi L "Possible indomethacin-aminoglycoside interaction in preterm infants." J Pediatr 107 (1985): 991-2. [PMID: 4067765]
74	Kovesi TA, Swartz R, MacDonald N "Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis." N Engl J Med 338 (1998): 65-6. [PMID: 9424574]
75	Scott CS, RetschBogart GZ, Henry MM "Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen." Pediat Pulm 31 (2001): 314-6. [PMID: 11288217]
76	Zarfin Y, Koren G, Maresky D, et al "Clinical and laboratory observations: possible indomethacin-aminoglycoside interaction in preterm infants." J Pediatr 106 (1985): 511-3. [PMID: 3973790]
77	Deleeuw PW "Nonsteroidal anti-inflammatory drugs and hypertension: the risks in perspective." Drugs 51 (1996): 179-87. [PMID: 8808162]
78	Product Information. Arthrotec (diclofenac-misoprostol). Searle, Skokie, IL.
79	Ring ME, Corrigan JJ, Fenster PE "Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin." Thromb Res 44 (1986): 391-400. [PMID: 3798404]
80	Fausa O "Salicylate-induced hypoprothrombinemia: a report of four cases." Acta Med Scand 188 (1970): 403-8. [PMID: 5490567]
81	Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (first of two parts)." N Engl J Med 285 (1971): 487-98. [PMID: 4397794]
82	Wells PS, Holbrook AM, Crowther NR, Hirsh J "Interactions of warfarin with drugs and food." Ann Intern Med 121 (1994): 676-83. [PMID: 7944078]
83	Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review.?Clin Toxicol (Phila). 2016;54(5):345-364. [PMID: 26919414]
84	Barrow MV, Quick DT, Cunningham RW "Salicylate hypoprothrombinemia in rheumatoid arthritis with liver disease. Report of two cases." Arch Intern Med 120 (1967): 620-4. [PMID: 6054600]
85	Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (second of two parts)." N Engl J Med 285 (1971): 547-58. [PMID: 4397794]
86	Penning-van Beest F, Erkens J, Petersen KU, Koelz HR, Herings R "Main comedications associated with major bleeding during anticoagulant therapy with coumarins." Eur J Clin Pharmacol 61 (2005): 439-44. [PMID: 15947920]
87	Weiss HJ, Aledort LM, Kochwa S "The effect of salicylates on the hemostatic properties of platelets in man." J Clin Invest 47 (1968): 2169-80. [PMID: 5675432]
88	Multum Information Services, Inc. Expert Review Panel.
89	Radack KL, Deck CC, Bloomfield SS "Ibuprofen interferes with the efficacy of antihypertensive drugs: a randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen." Ann Intern Med 107 (1987): 628-35. [PMID: 2889416]
90	Ahmad S "Indomethacin-enalapril interaction: an alert." South Med J 84 (1991): 411-2. [PMID: 2000541]
91	Silberbauer K, Stanek B, Templ H "Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition." Br J Clin Pharmacol 14 (1982): s87-93. [PMID: 6753910]
92	Townend JN, Doran J, Lote CJ, Davies MK "Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril." Br Heart J 73 (1995): 434-41. [PMID: 7786658]
93	Baer PA, Shore A, Ikeman RL "Transient fall in serum salicylate levels following intraarticular injection of steroid in patients with rheumatoid arthritis." Arthritis Rheum 30 (1987): 345-7. [PMID: 3566826]
94	Edelman J, Potter JM, Hackett LP "The effect of intra-articular steroids on plasma salicylate concentrations." Br J Clin Pharmacol 21 (1986): 301-7. [PMID: 3485989]
95	Hansen RA, Tu W, Wang J, Ambuehl R, McDonald CJ, Murray MD "Risk of adverse gastrointestinal events from inhaled corticosteroids." Pharmacotherapy 28 (2008): 1325-34. [PMID: 18956992]
96	Koren G, Roifman C, Gelfand E, Lavi S, Suria D, Stein L "Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis." Ther Drug Monit 9 (1987): 177-9. [PMID: 3617157]
97	Piper JM, Ray WA, Daugherty JR, Griffin MR "Corticosteroid use and peptic ulcer disease: role of nonsteroidal ani-inflammatory drugs." Ann Intern Med 114 (1991): 735-40. [PMID: 2012355]
98	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
99	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
100	Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
101	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
102	Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
103	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
104	Product Information. Penetrex (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA.
105	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
106	Ball P, Tillotson G "Tolerability of fluoroquinolone antibiotics: past, present and future." Drug Saf 13 (1996): 343-8. [PMID: 8652079]
107	Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
108	Domagala JM "Structure-activity and structure-side-effect relationships for the quinolone antibacterials." J Antimicrob Chemother 33 (1994): 685-706. [PMID: 8056688]
109	Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
110	Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
111	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
112	Alderman CP, Moritz CK, Ben-Tovim DI "Abnormal platelet aggregation associated with fluoxetine therapy." Ann Pharmacother 26 (1992): 1517-9. [PMID: 1482806]
113	Alderman CP, Seshadri P, Ben-Tovim DI "Effects of serotonin reuptake inhibitors on hemostasis." Ann Pharmacother 30 (1996): 1232-4. [PMID: 8913401]
114	Aranth J, Lindberg C "Bleeding, a side effect of fluoxetine." Am J Psychiatry 149 (1992): 412. [PMID: 1536285]
115	Bannister SJ, Houser VP, Hulse JD, Kisicki JC, Rasmussen JG "Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin." Acta Psychiatr Scand Suppl 350 (1989): 102-6. [PMID: 2530759]
116	Ciraulo DA, Shader RI "Fluoxetine drug-drug interactions. II." J Clin Psychopharmacol 10 (1990): 213-7. [PMID: 2198298]
117	Claire RJ, Servis ME, Cram DL Jr "Potential interaction between warfarin sodium and fluoxetine." Am J Psychiatry 148 (1991): 1604. [PMID: 1928485]
118	Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH "Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study." Arch Intern Med 163 (2003): 59-64. [PMID: 12523917]
119	de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S "Intracranial haemorrhage and use of selective serotonin reuptake inhibitors." Br J Clin Pharmacol 50 (2000): 43-7. [PMID: 10886117]
120	de Abajo FJ, Rodriguez LA, Montero D "Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study." BMJ 319 (1999): 1106-9. [PMID: 10531103]
121	de Maistre E, Allart C, Lecompte T, Bollaert PE "Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors." Am J Med 113 (2002): 530-2. [PMID: 12427509]
122	Dent LA, Orrock MW "Warfarin-fluoxetine and diazepam-fluoxetine interaction." Pharmacotherapy 17 (1997): 170-2. [PMID: 9017779]
123	Ford MA, Anderson ML, Rindone JP, Jaskar DW "Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin." J Clin Psychopharmacol 17 (1997): 110-2. [PMID: 10950474]
124	Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B "Paroxetine decreases platelet serotonin storage and platelet function in human beings." Clin Pharmacol Ther 68 (2000): 435-42. [PMID: 11061584]
125	Humphries JE, Wheby MS, VandenBerg SR "Fluoxetine and the bleeding time." Arch Pathol Lab Med 114 (1990): 727-8. [PMID: 2363631]
126	Krivy J, Wiener J "Sertraline and platelet counts in idiopathic thrombocytopenia purpura." Lancet 345 (1995): 132. [PMID: 7815874]
127	Leung M, Shore R "Fluvoxamine-associated bleeding." Can J Psychiatry 41 (1996): 604-5. [PMID: 8946088]
128	Messiha FS "Fluoxetine - adverse effects and drug-drug interactions." J Toxicol Clin Toxicol 31 (1993): 603-30. [PMID: 8254702]
129	Ottervanger JP, Stricker BH, Huls J, Weeda JN "Bleeding attributed to the intake of paroxetine." Am J Psychiatry 151 (1994): 781-2. [PMID: 8166328]
130	Pai VB, Kelly MW "Bruising associated with the use of fluoxetine." Ann Pharmacother 30 (1996): 786-8. [PMID: 8826562]
131	Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
132	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
133	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
134	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
135	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
136	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
137	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
138	Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
139	Product Information. Pristiq (desvenlafaxine). Wyeth Laboratories, Philadelphia, PA.
140	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
141	Product Information. Savella (milnacipran). Forest Pharmaceuticals, St. Louis, MO.
142	Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
143	Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
144	Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
145	Skop BP, Brown TM "Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors." Psychosomatics 37 (1996): 12-6. [PMID: 8600488]
146	Woolfrey S, Gammack NS, Dewar MS, Brown PJ "Fluoxetine-warfarin interaction." BMJ 307 (1993): 241. [PMID: 8369688]
147	Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ "Fluoxetine and bleeding in obsessive-compulsive disorder." Am J Psychiatry 148 (1991): 949. [PMID: 2053641]
148	Layton D, Clark DWJ, Pearce GL, Shakir SAW "Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England." Eur J Clin Pharmacol 57 (2001): 167-76. [PMID: 11417450]
149	Tata LJ, Fortun PJ, Hubbard RB, et al. "Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?" Aliment Pharmacol Ther 22 (2005): 175-81. [PMID: 16091054]
150	Product Information. Plavix (clopidogrel). Bristol-Myers Squibb, Princeton, NJ.
151	Branthwaite JP, Nicholls A "Cyclosporin and diclofenac interaction in rheumatoid arthritis." Lancet 337 (1991): 252. [PMID: 1670893]
152	Brouwers JRBJ, Desmet PAGM "Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs." Clin Pharmacokinet 27 (1994): 462-85. [PMID: 7882636]
153	Deray G, Le Hoang P, Aupetit B, Achour A, Rottembourg J, Baumelou A "Enhancement of cyclosporine A nephrotoxicity by diclofenac." Clin Nephrol 27 (1987): 213-4. [PMID: 2953512]
154	Harris KP, Jenkins D, Walls J "Nonsteroidal antiinflammatory drugs and cyclosporine." Transplantation 46 (1988): 598-9. [PMID: 3176159]
155	Sesin GP, O'Keefe E, Roberto P "Sulindac-induced elevation of serum cyclosporine concentration." Clin Pharm 8 (1989): 445-6. [PMID: 2663332]
156	Rodin SM, Johnson BF "Pharmacokinetic interactions with digoxin." Clin Pharmacokinet 15 (1988): 227-44. [PMID: 3056649]
157	Finch MB, Johnston GD, Kelly JG, McDevitt DG "Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy." Br J Clin Pharmacol 17 (1984): 353-5
158	Jorgensen HS, Christensen HR, Kampmann JP "Interaction between digoxin and indomethacin or ibuprofen." Br J Clin Pharmacol 31 (1991): 108-10
159	Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
160	Ponce SP, Jennings AE, Madias NE, Harrington JT "Drug-induced hyperkalemia." Medicine (Baltimore) 64 (1985): 357-70. [PMID: 2865667]
161	Abdel-Haq B, Magagna A, Favilla S, Salvetti A "Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects." J Cardiovasc Pharmacol 18 (1991): s33-6. [PMID: 1725198]
162	Allon M, Pasque CB, Rodriguez M "Interaction of captopril and ibuprofen on glomerular and tubular function in humans." Am J Physiol 259 (1990): f233-8. [PMID: 2201204]
163	Product Information. Inspra (eplerenone). Searle, Chicago, IL.
164	Morgan T, Anderson A "Interaction of indomethacin with felodipine and enalapril." J Hypertens 11 (1993): S338-9. [PMID: 8158412]
165	Polonia J, Boaventura I, Gama G, Camoes I, Bernardo F, Andrade P, Nunes JP, Brandao F, Cerqueiragomes M "Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients." J Hypertens 13 (1995): 925-31. [PMID: 8557971]
166	Moore TJ, Crantz FR, Hollenberg NK "Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension." Hypertension 3 (1981): 168-73. [PMID: 6260645]
167	Seto S, Aoi W, Iwami K, et al "Effect of propranolol and indomethacin on the depressor action of captopril in patients with essential hypertension." Clin Exp Hypertens 9 (1987): 623-7. [PMID: 3301085]
168	Product Information. Flolan (epoprostenol). Glaxo Wellcome, Research Triangle Park, NC.
169	Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
170	Product Information. Ventavis (iloprost). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
171	Abad S, Moachon L, Blanche P, Bavoux F, Sicard D, Salmon-Ceron D "Possible interaction between glicazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia." Br J Clin Pharmacol 52 (2001): 456-7. [PMID: 11678792]
172	Ahmad S "Drug interaction induces hypoglycemia." J Fam Pract 40 (1995): 540-1. [PMID: 7775905]
173	Ahmad S "Gemfibrozil: interaction with glyburide." South Med J 84 (1991): 102. [PMID: 1898783]
174	Aleyassine H, Gardiner RJ "Dual action of antidepressant drugs (MAO inhibitors) on insulin release." Endocrinology 96 (1975): 702-10. [PMID: 1090438]
175	Aleyassine H, Lee SH "Inhibition of insulin release by substrates and inhibitors of monoamine oxidase." Am J Physiol 222 (1972): 565-9. [PMID: 5022664]
176	Almirall J, Montoliu J, Torras A, Revert L "Propoxyphene-induced hypoglycemia in a patient with chronic renal failure." Nephron 53 (1989): 273-5. [PMID: 2797348]
177	Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P "Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy." Am J Med 89 (1990): 811-3. [PMID: 2123605]
178	Asplund K, Wiholm BE, Lithner F "Glibenclamide-associated hypoglycaemia: a report on 57 cases." Diabetologia 24 (1983): 412-7. [PMID: 6411511]
179	Baciewicz AM, Swafford WB Jr "Hypoglycemia induced by the interaction of chlorpropamide and co-trimoxazole." Drug Intell Clin Pharm 18 (1984): 309-10. [PMID: 6609055]
180	Barbato M "Another problem with Kinidin." Med J Aust 141 (1984): 685. [PMID: 6436654]
181	Baron SH "Salicylates as hypoglycemic agents." Diabetes Care 5 (1982): 64-71. [PMID: 6754304]
182	Cacoub P, Deray G, Baumelou A, Grimaldi A, Soubrie C, Jacobs C "Disopyramide-induced hypoglycemia: case report and review of the literature." Fundam Clin Pharmacol 3 (1989): 527-35. [PMID: 2691378]
183	Cattaneo AG, Caviezel F, Pozza G "Pharmacological interaction between tolbutamide and acetylsalicylic acid: study on insulin secretion in man." Int J Clin Pharmacol Ther Toxicol 28 (1990): 229-34. [PMID: 2198232]
184	Cooper AJ, Ashcroft G "Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs." Lancet 1 (1966): 407-9. [PMID: 4159787]
185	Croxson MS, Shaw DW, Henley PG, Gabriel HDLL "Disopyramide-induced hypoglycaemia and increased serum insulin." N Z Med J July (1987): 407-8. [PMID: 3330586]
186	Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31. [PMID: 8845455]
187	Daubresse JC, Daigneux D, Bruwier M, Luyckx A, Lefebvre PJ "Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents." Br J Clin Pharmacol 7 (1979): 599-603. [PMID: 380614]
188	Daubresse JC, Luyckx AS, Lefebvre PJ "Potentiation of hypoglycemic effect of sulfonylureas by clofibrate." N Engl J Med 294 (1976): 613. [PMID: 1246250]
189	David DS, Steere AC Jr, Pi-Sunyer XF, Sakai S, Clark SB "Aspirin-induced hypoglycaemia in a patient on haemodialysis." Lancet 2 (1971): 1092-3. [PMID: 4106934]
190	Davis TM, Karbwang J, Looareesuwan S, et al "Comparative effects of quinine and quinidine on glucose metabolism in healthy volunteers." Br J Clin Pharmacol 30 (1990): 397-403. [PMID: 2223418]
191	de Salcedo I, Gorringe AL, Silva JL, Santos JA "Gemfibrozil in a group of diabetics." Proc R Soc Med 69 (1976): 64-70. [PMID: 1019155]
192	Deeg MA, Lipkin EW "Hypoglycemia associated with the use of fluoxetine." West J Med 164 (1996): 262-3. [PMID: 8775944]
193	Diwan PV, Sastry MS, Satyanarayana NV "Potentiation of hypoglycemic response of glibenclamide by piroxicam in rats and humans." Indian J Exp Biol 30 (1992): 317-9. [PMID: 1459600]
194	Feher MD, Amiel S "ACE inhibitors and hypoglycaemia." Lancet 346 (1995): 125-6. [PMID: 7603199]
195	Feldman JM, Chapman B "Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insulin secretion." Diabetologia 11 (1975): 487-94. [PMID: 1107123]
196	Ferrari C, Fressati S, Romussi M, et al. "Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia." Metabolism 26 (1977): 129-39. [PMID: 834147]
197	Ferriere M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J "Captopril and insulin sensitivity." Ann Intern Med 102 (1985): 134-5. [PMID: 3881067]
198	Fogari R, Zoppi A, Corradi L, Pierangelo L, Mugellini A, Lusardi P "Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertension." Br J Clin Pharmacol 46 (1998): 467-71. [PMID: 9833600]
199	Giugliano D, Ceriello A, Saccomanno F, et al "Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus." J Clin Endocrinol Metab 61 (1985): 160-6. [PMID: 3923028]
200	Goldberg IJ, Brown LK, Rayfield EJ "Disopyramide (norpace)-induced hypoglycemia." Am J Med 69 (1980): 463-6. [PMID: 6998294]
201	Harris EL "Adverse reactions to oral antidiabetic agents." Br Med J 3 (1971): 29-30. [PMID: 5091891]
202	Harrison LC, King-Roach A, Martin FI, Melick RA "The effect of fenfluramine on insulin binding and on basal and insulin-stimulated oxidation of 1-C-glucose by human adipose tissue." Postgrad Med J 51 Suppl 1 (1975): 110-4. [PMID: 1219664]
203	Hartmann D, Korn A, Komjati M, Heinz G, Haefelfinger P, Defoin R, Waldhausl WK "Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide." Br J Clin Pharmacol 30 (1990): 245-52. [PMID: 2119677]
204	Hayashi S, Horie M, Tsuura Y, Ishida H, Okada Y, Seino Y, Sasayama S "Disopyramide blocks pancreatic ATP-sensitive K+ channels and enhances insulin release." Am J Physiol 265 (1993): c337-42. [PMID: 8368263]
205	Hekimsoy Z, Biberoglu S, Comlekci A, Tarhan O, Mermut C, Biberoglu K "Trimethoprim/sulfamethoxazole-induced hypoglycemia in a malnourished patient with severe infection." Eur J Endocrinol 136 (1997): 3046. [PMID: 9100556]
206	Hellman B "Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells." Metabolism 23 (1974): 839-46. [PMID: 4212254]
207	Herings RMC, Deboer A, Stricker BHC, Leufkens HGM, Porsius A "Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme." Lancet 345 (1995): 1195-8. [PMID: 7739305]
208	Hundal RS, Petersen KF, Mayerson AB, et al "Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes." J Clin Invest 109 (2002): 1321-6. [PMID: 12021247]
209	Iida H, Morita T, Suzuki E, Iwasawa K, Toyooka T, Nakajima T "Hypoglycemia induced by interaction between clarithromycin and disopyramide." Jpn Heart J 40 (1999): 91-6. [PMID: 10370402]
210	Johnson J, Dobmeier M "Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction." DICP 24 (1990): 250-1. [PMID: 2316232]
211	Johnson JA, Kappel JE, Sharif MN "Hypoglycemia secondary to trimethoprim/sulfamethoxazole administration in a renal transplant patient." Ann Pharmacother 27 (1993): 304-6. [PMID: 8453166]
212	Konttinen A, Kuisma I, Ralli R, Pohjola S, Ojala K "The effect of gemfibrozil on serum lipids in diabetic patients." Ann Clin Res 11 (1979): 240-5. [PMID: 398183]
213	Kradjan WA, Witt DM, Opheim KE, Wood FC "Lack of interaction between glipizide and co-trimoxazole." J Clin Pharmacol 34 (1994): 997-1002. [PMID: 7836551]
214	Kubacka RT, Antla EJ, Juhl RP, Welshman IR "Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects." Ann Pharmacother 30 (1996): 20-6. [PMID: 8773160]
215	Lozada A, Dujovne CA "Drug interactions with fibric acids." Pharmacol Ther 63 (1994): 163-76. [PMID: 7809177]
216	Lumholtz B, Siersbaek-Nielsen K, Skovsted L, Kampmann J, Hansen JM "Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism." Clin Pharmacol Ther 17 (1975): 731-4. [PMID: 1139863]
217	Morris AD, Newton RW, Boyle DI, et al. "ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes." Diabetes Care 20 (1997): 1363-7. [PMID: 9283780]
218	Morrison PJ, Rogers HJ, Spector RG, Bradbrook ID, John VA "Effect of pirprofen on glibenclamide kinetics and response." Br J Clin Pharmacol 14 (1982): 123-6. [PMID: 6809024]
219	Murakami K, Nambu S, Koh H, Kobayashi M, Shigeta Y "Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus." Br J Clin Pharmacol 17 (1984): 89-91. [PMID: 6362704]
220	Nakabayashi H, Ito T, Igawa T, Hiraiwa Y, Imamura T, Seta T, Kawato M, Usukura N, Takeda R "Disopyramide induces insulin secretion and plasma glucose diminution: studies using the in situ canine pancreas." Metabolism 38 (1989): 179-83. [PMID: 2643753]
221	Nappi JM, Dhanani S, Lovejoy JR, VanderArk C "Severe hypoglycemia associated with disopyramide." West J Med 138 (1983): 95-7. [PMID: 6404062]
222	Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivisto KT "Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride." Clin Pharmacol Ther 69 (2001): 194-200. [PMID: 11309547]
223	Nikkila EA, Ylikahri R, Huttunen JK "Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia." Proc R Soc Med 69 (1976): 58-63. [PMID: 190608]
224	Paolisso G, Balbi V, Gambardella A, Varricchio G, Tortoriello R, Saccomanno F, Amato L, Varricchio M "Lisinopril administration improves insulin action in aged patients with hypertension." J Hum Hypertens 9 (1995): 541-6. [PMID: 7562882]
225	Pestell RG, Crock PA, Ward GM, Alford FP, Best JD "Fenfluramine increases insulin action in patients with NIDDM." Diabetes Care 12 (1989): 252-8. [PMID: 2495916]
226	Petitpierre B, Perrin L, Rudhardt M, et al "Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy." Int J Clin Pharmacol 6 (1972): 120-4. [PMID: 4638970]
227	Phillips AF, Matty PJ, Porte PJ, Raye JR "Inhibition of glucose-induced insulin secretion by indomethacin and sodium salicylate in the fetal lamb." Am J Obstet Gynecol 148 (1984): 481-7. [PMID: 6364813]
228	Phillips RE, Looareesuwan S, White NJ, et al "Hypoglycaemia and antimalarial drugs: quinidine and release of insulin." Br Med J 292 (1986): 1319-21. [PMID: 3085830]
229	Pollak PT, Mukherjee SD, Fraser AD "Sertraline-induced hypoglycemia." Ann Pharmacother 35 (2001): 1371-4. [PMID: 11724085]
230	Pond SM, Birkett DJ, Wade DN "Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole." Clin Pharmacol Ther 22 (1977): 573-9. [PMID: 913025]
231	Prince RL, Larkins RG, Alford FP "The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects." Metabolism 30 (1981): 293-8. [PMID: 7010074]
232	Product Information. Amaryl (glimepiride). Hoechst Marion-Roussel Inc, Kansas City, MO.
233	Product Information. Apidra (insulin glulisine). Aventis Pharmaceuticals, Bridgewater, NJ.
234	Product Information. Diabeta (glyburide). Hoechst Marion-Roussel Inc, Kansas City, MO.
235	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
236	Product Information. Dymelor (acetohexamide) Lilly, Eli and Company, Indianapolis, IN.
237	Product Information. Glucotrol (glipizide). Pfizer US Pharmaceuticals, New York, NY.
238	Product Information. Increlex (mecasermin). Tercica Inc, Brisbane, CA.
239	Product Information. Micronase (glyburide). Pharmacia and Upjohn, Kalamazoo, MI.
240	Product Information. Orinase (tolbutamide) Pharmacia and Upjohn, Kalamazoo, MI.
241	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
242	Product Information. Starlix (nateglinide) Novartis Pharmaceuticals, East Hanover, NJ.
243	Product Information. Tolinase (tolazamide) Pharmacia and Upjohn, Kalamazoo, MI.
244	Quevedo SF, Krauss DS, Chazan JA, et al "Fasting hypoglycemia secondary to disopyramide therapy." JAMA 245 (1981): 2424. [PMID: 6785461]
245	Ravic M, Johnston A, Turner P "Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs." Postgrad Med J 66 (1990): s30-4. [PMID: 2126624]
246	Richardson T, Foster J, Mawer GE "Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects." Br J Clin Pharmacol 22 (1986): 43-8. [PMID: 3527244]
247	Rubin M, Zakheim B, Pitchumoni C "Disopyramide-induced profound hypoglycemia." N Y State J Med July,Aug,S (1983): 1057-8. [PMID: 6579404]
248	Salmela PI, Sotaniemi EA, Viikari J, et al "Fenfluramine therapy in non-insulin-dependent diabetic patients effects on body weight, glucose homeostasis, serum lipoproteins, and antipyrine metabolism." Diabetes Care 4 (1981): 535-40. [PMID: 6751729]
249	Sawka AM, Burgart V, Zimmerman D "Loss of awareness of hypoglycemia temporally associated with selective serotonin reuptake inhibitors." Diabetes Care 24 (2001): 1845-6. [PMID: 11574457]
250	Semel JD, Wortham E, Karl DM "Fasting hypoglycemia associated with disopyramide." Am Heart J 106 (1983): 1160-1. [PMID: 6356848]
251	Shah SJ, Bhandarkar SD, Satoskar RS "Drug interaction between chlorpropamide and non-steroidal anti-flammatory drugs, ibuprofen and phenylbutazone." Int J Clin Pharmacol Ther Toxicol 22 (1984): 470-2. [PMID: 6500764]
252	Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V "Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia." Eur J Clin Nutr 57 (2003): 243-8. [PMID: 12571655]
253	Sjoberg S, Wiholm BE, Gunnarsson R, Emilsson H, Thunberg E, Christenson I, Ostman J "Lack of pharmacokinetic interaction between glibenclamide and trimethoprim-sulphamethoxazole." Diabet Med 4 (1987): 245-7. [PMID: 2956028]
254	Slade IH, and Iosefa RN "Fatal hypoglycemic coma from the use of tolbutamide in elderly patients: report of two cases." J Am Geriatr Soc 15 (1967): 948-50. [PMID: 6046558]
255	Sone H, Takahashi A, Yamada N "Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea." Ann Intern Med 134 (2001): 344. [PMID: 11182854]
256	Storlien LH, Thorburn AW, Smythe GA, Jenkins AB, Chisholm DJ, Kraegen EW "Effect of d-fenfluramine on basal glucose turnover and fat-feeding-induced insulin resistance in rats." Diabetes 38 (1989): 499-503. [PMID: 2647557]
257	Strathman I, Schubert EN, Cohen A, Nitzberg DM "Hypoglycemia in patients receiving disopyramide phosphate." Drug Intell Clin Pharm 17 (1983): 635-8. [PMID: 6413187]
258	Tannenbaum H, Anderson LG, Soeldner JS "Phenylbutazone-tolbutamide drug interaction." N Engl J Med 290 (1974): 344. [PMID: 4809290]
259	Tran PO, Gleason CE, Robertson RP "Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function." Diabetes 51 (2002): 1772-8. [PMID: 12031964]
260	Tremaine LM, Wilner KD, Preskorn SH "A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide." Clin Pharmacokinet 32(Suppl 1) (1997): 31-36. [PMID: 9068933]
261	Verdy M, Charbonneau L, Verdy I, Belanger R, Bolte E, Chiasson JL "Fenfluramine in the treatment of non-insulin-dependent diabetics: hypoglycemic versus anorectic effect." Int J Obes 7 (1983): 289-97. [PMID: 6629637]
262	Vuksan V, Sievenpiper JL, Koo VY, et al "American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus." Arch Intern Med 160 (2000): 1009-13. [PMID: 10761967]
263	Vuksan V, Stavro MP, Sievenpiper JL, et al "Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes." Diabetes Care 23 (2000): 1221-6. [PMID: 10977009]
264	Whitcroft IA, Thomas JM, Rawsthorne A, et al "Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics." Horm Metab Res Suppl 22 (1990): 42-6. [PMID: 1975246]
265	Wiederholt IC, Genco M, Foley JM "Recurrent episodes of hypoglycemia induced by propoxyphene." Neurology 17 (1967): 703-6. [PMID: 6067489]
266	Wing LM, Miners JO "Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition." Br J Clin Pharmacol 20 (1985): 482-5. [PMID: 3878154]
267	World Health Organization "WHO Public Assessment Reports (WHOPARs).".
268	Wu B, Sato T, Kiyosue T, Arita M "Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs." Cardiovasc Res 26 (1992): 1095-101. [PMID: 1291087]
269	Cinquegrani MP, Liang CS "Indomethacin attenuates the hypotensive action of hydralazine." Clin Pharmacol Ther 39 (1986): 564-70
270	Graham DY, Malaty HM "Alendronate and naproxen are synergistic for development of gastric ulcers." Arch Intern Med 161 (2001): 107-10. [PMID: 11146706]
271	Graham, Malaty "Alendronate and naproxen are synergistic for development of gastric ulcers (Vol 161, pg 107, 1921)." Arch Intern Med 161 (2001): 1862. [PMID: 11146706]
272	Product Information. Aredia (pamidronate). Novartis Pharmaceuticals, East Hanover, NJ.
273	Product Information. Boniva (ibandronate). Roche Laboratories, Nutley, NJ.
274	Product Information. Didronel Tablets (etidronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
275	Product Information. Fosamax (alendronate). Merck & Co, Inc, West Point, PA.
276	Product Information. Zometa (zoledronic acid). Novartis Pharmaceuticals, East Hanover, NJ.
277	Juarez-Olguin H, Jung-Cook H, Flores-Perez J, Asseff IL "Clinical Evidence of an Interaction Between Imipramine and Acetylsalicylic Acid on Protein Binding in Depressed Patients." Clin Neuropharmacol 25 (2002): 32-36. [PMID: 11852294]
278	Ben Salem C, Fathallah N, Hmouda H, Bouraoui K "Drug-induced hypoglycaemia: an update." Drug Saf 34 (2011): 21-45. [PMID: 20942513]
279	Product Information. Afrezza (insulin inhalation, rapid acting). MannKind Corporation, Valencia, CA.
280	Product Information. Humalog (insulin lispro). Lilly, Eli and Company, Indianapolis, IN.
281	Product Information. Humulin 70/30 (insulin isophane-insulin regular). Lilly, Eli and Company, Indianapolis, IN.
282	Product Information. Ryzodeg 70/30 FlexTouch (insulin aspart-insulin degludec). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
283	Product Information. Tresiba FlexTouch (insulin degludec). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
284	Vuorinen-Markkola H, Yki-Jarvinen H "Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus." Metabolism 44 (1995): 85-9. [PMID: 7854171]
285	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
286	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
287	Product Information. Sodium Iodide I-123 (sodium iodide I-123). GE Healthcare, Princeton, NJ.
288	Berg KJ "Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency." Eur J Clin Pharmacol 11 (1977): 111-6. [PMID: 837963]
289	Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT "Diuresis or urinary alkalinisation for salicylate poisoning?" Br Med J (Clin Res Ed) 285 (1982): 1383-6. [PMID: 6291695]
290	Tietjen DP "Recurrence and specificity of nephrotic syndrome due to tolmetin." Am J Med 87 (1989): 354-5
291	Shand DG, Epstein C, Kinberg-Calhoun J, et al "The effect of etodolac administration on renal function in patients with arthritis." J Clin Pharmacol 26 (1986): 269-74
292	Turner GA, Walker RJ, Bailey RR, et al "Sulindac-induced acute interstitial nephritis." N Z Med J 97 (1984): 239-40
293	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
294	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
295	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
296	Balali-Mood M, Prescott LF "Failure of alkaline diuresis to enhance diflunisal elimination." Br J Clin Pharmacol 10 (1980): 163-5. [PMID: 7426277]
297	Berg KJ "Acute acetylsalicylic acid poisoning: treatment with forced alkaline diuresis and diuretics." Eur J Clin Pharmacol 12 (1977): 111-6. [PMID: 21797]
298	Product Information. Folotyn (pralatrexate). Allos Therapeutics, Westminster, CO.
299	Product Information. Effient (prasugrel). Lilly, Eli and Company, Indianapolis, IN.
300	Diamond JS, Paolino JS "Evidence for a postsecretory reabsorptive site for uric acid in man." J Clin Invest 52 (1973): 1491-9. [PMID: 4703233]
301	Harris M, Bryant LR, Danaher P, Alloway J "Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis." J Rheumatol 27 (2000): 2873-6. [PMID: 11128679]
302	Regal RE "Aspirin and uricosurics: interaction revisited." Drug Intell Clin Pharm 21 (1987): 219-20. [PMID: 3829916]
303	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
304	Abbott FS, Kassam J, Orr JM, Farrell K "The effect of aspirin on valproic acid metabolism." Clin Pharmacol Ther 40 (1986): 94-100. [PMID: 3087680]
305	Dasgupta A, Jacques M "Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera - role of uremic compounds." Am J Clin Pathol 101 (1994): 349-53. [PMID: 8135194]
306	Farrell K, Orr JM, Abbott FS, et al "The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children." J Pediatr 101 (1982): 142-4. [PMID: 6806458]
307	Orr JM, Abbott FS, Farrell K, Ferguson S, Sheppard I, Godolphin W "Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects." Clin Pharmacol Ther 31 (1982): 642-9. [PMID: 6804150]
308	Zanchetti A, Hansson L, Leonetti G, et al. "Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy." J Hypertens 20 (2002): 1015-1022. [PMID: 12011664]
309	Sziegoleit W, Rausch J, Polak G, et al "Influence of acetylsalicylic acid on acute circulatory effects of the beta-blocking agents pindolol and propranolol in humans." Int J Clin Pharmacol Ther Toxicol 20 (1982): 423-30
310	Keber I, Jerse M, Keber D, Stegnar M "The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease." Br J Clin Pharmacol 7 (1979): 287-91
311	Bartoli E, Arras S, Faedda R, Soggia G, Satta A, Olmeo NA "Blunting of furosemide diuresis by aspirin in man." J Clin Pharmacol 20 (1980): 452-8
312	Valette H, Apoil E "Interaction between salicylate and two loop diuretics." Br J Clin Pharmacol 8 (1979): 592-4
313	Cheng Z, Radominska-Pandya A, Tephly TR. Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. Drug Metab Dispos. 1999 Oct;27(10):1165-70.
314	Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
315	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
316	Product Information. Vitrase (hyaluronidase). Bausch and Lomb, Rochester, NY.
317	Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
318	Saeed SA, Gilani AH "Antithrombotic activity of clove oil." J Pak Med Assoc 44 (1994): 112-5. [PMID: 8078176]
319	Srivasta KC "Antiplatelet principles from a food spice clove (Syzygium aromaticum L) [corrected]" Prostaglandins Leukot Essent Fatty Acids 48 (1993): 363-72. [PMID: 8321872]
320	Srivstava KC, Malhotra N "Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets." Prostaglandins Leukot Essent Fatty Acids 42 (1991): 73-81. [PMID: 2011614]
321	Miner PB Jr, Fort JG, Zhang Y. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325?mg + immediate-release omeprazole 40?mg) or enteric-coated aspirin 325?mg + enteric-coated omeprazole 40?mg - a randomised, phase 1, crossover study.?Aliment Pharmacol Ther. 2013;38(1):62-71. [PMID: 23692061]
322	Inarrea P, Esteva F, Cornudella R, Lanas A "Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man." Scand J Gastroenterol 35 (2000): 242-6. [PMID: 10766315]
323	Nefesoglu FZ, Ayanoglu-Dulger G, Ulusoy NB, Imeryuz N "Interaction of omeprazole with enteric-coated salicylate tablets." Int J Clin Pharmacol Ther 36 (1998): 549-53. [PMID: 9799060]
324	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
325	Fraser DG, Ludden TM, Evens RP, Sutherland EW "Displacement of phenytoin from plasma binding sites by salicylate." Clin Pharmacol Ther 27 (1980): 165-9. [PMID: 7353334]
326	Leonard RF, Knott PJ, Rankin GO, et al "Phenytoin-salicylate interaction." Clin Pharmacol Ther 29 (1981): 56-60. [PMID: 7460475]
327	Lunde PK, Rane A, Yaffe SJ, Lund L, Sjoqvist F "Plasma protein binding of diphenylhydantoin in man: interaction with other drugs and the effect of temperature and plasma dilution." Clin Pharmacol Ther 11 (1970): 846-55. [PMID: 4394754]
328	Neuvonen PJ, Lehtovaara R, Bardy A, Elomaa E "Antipyretic analgesics in patients on antiepileptic drug therapy." Eur J Clin Pharmacol 15 (1979): 263-8. [PMID: 314381]
329	Paxton JW "Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects." Clin Pharmacol Ther 27 (1980): 170-8. [PMID: 7353335]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence